SurgeryHaematology
Perioperative Anticoagulant Management
Risk-balance bleeding vs thrombosis; warfarin bridging strategies; DOAC interruption; antiplatelet decisions.
Source: ACCP 2018; BSH 2016; NICE NG89
Step 1 of ~6
info
Risk Stratification
Balance:
• Surgical bleeding risk (low / moderate / high).
• Patient thromboembolic risk (low / moderate / high).
Thrombotic risk categories:
• HIGH: mechanical mitral valve, CHA₂DS₂-VASc ≥7, recent VTE <3 months, severe thrombophilia.
• MODERATE: CHA₂DS₂-VASc 5–6, VTE 3–12 months, mechanical aortic valve with extra risk.
• LOW: CHA₂DS₂-VASc ≤4, VTE >12 months, mechanical bileaflet aortic valve no risk.
Surgical bleeding risk:
• HIGH: cardiac, neurosurgery, major abdominal/urological/vascular.
• MODERATE: orthopaedic, colectomy, pacemaker.
• LOW: dental, cataract, skin, endoscopy without biopsy / polypectomy.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Warfarin · Anticoagulant
- Warfarin · Vitamin K Antagonist (Anticoagulant)
- Apixaban · Direct Oral Anticoagulant (DOAC) — Factor Xa Inhibitor
- Rivaroxaban · Direct oral anticoagulant (DOAC) — Factor Xa inhibitor
- Apixaban · Direct oral anticoagulant (DOAC) — Factor Xa inhibitor
- Warfarin · Vitamin K Antagonist Anticoagulant
Pathways
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH
Decision support only. Always apply local guidelines and clinical judgement.